Concepedia

Kasper van der Born

KV

Statistics

Publications

14

Citations

1K

H-Index

12

Active since

2002

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

University Medical Center

Taiho Pharmaceutical (Japan)

Montefiore Medical Center

University Hospital and Clinics

Kasper van der Born is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, pharmacology, and oncology.

Top concepts

Publications per year

2002–2009

14

Publications

14

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin

M. Borner, Patrick Schöffski, Ronald de Wit et al. · European Journal of Cancer · 2002 · 314 citations

, , +4

Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung

Bart P.H. Wittgen, Peter W.A. Kunst, Kasper van der Born et al. · Clinical Cancer Research · 2007 · 167 citations

The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates

Peter R. Wielinga, Jan Hendrik Hooijberg, Sjöfn Gunnarsdottir et al. · Cancer Research · 2005 · 138 citations · Full text

Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer

J. Sigmond, Richard J. Honeywell, Tjeerd J. Postma et al. · Annals of Oncology · 2008 · 89 citations · Full text

, , +5

Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity

Michiel de Bruin, T. van Capel, Kasper van der Born et al. · British Journal of Cancer · 2003 · 70 citations · Full text

1–5 of 14